DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/v2356k/glycated) has announced the addition of the "Glycated Haemoglobin (HbA1c) Testing Market" report to their offering.
Diabetes is a chronic disease growing at an alarming rate across the globe. Over 382 million people are estimated to be currently suffering from the disease; the number is likely to increase to 592 million by 2035.
The Glycated Haemoglobin (HbA1c) Testing Market, 2014-2024 report provides an exhaustive study of the growing market for HbA1c tests. Amongst other things, the report identifies HbA1c analyzers that are currently available for point of care and laboratory testing, and the high level trends which are likely to govern the evolution of this market in the US, EU5 and BRICS countries. The report also provides a competitive landscape wherein we have identified the most efficient POC devices in the market based on parameters such as user friendliness and other technical details.
One of the key objectives of this report is to understand the current and future state of the HbA1c diabetes monitoring market across various regions worldwide.
This is done by analyzing the following:
- Prevalence and growth of diabetes in different countries
- Number of patients going for HbA1c tests
- Frequency of HbA1c test per patient per year
- Variable price points
- Other technical details such as sample volume required, time taken for analysis, precision etc.
We have also provided a detailed view on the key drivers behind the growth of this market, likely challenges and upcoming threats under the SWOT framework. The base year for the report is 2014. The report provides mid -long term market forecasts for the period 2014 - 2024.
For more information visit http://www.researchandmarkets.com/research/v2356k/glycated